scispace - formally typeset
Open AccessJournal ArticleDOI

Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects

Reads0
Chats0
TLDR
Brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.
Abstract
Although structural brain alterations in schizophrenia have been demonstrated extensively, their quantitative distribution has not been studied over the last 14 years despite advances in neuroimaging. Moreover, a volumetric meta-analysis has not been conducted in antipsychotic-naive patients. Therefore, meta-analysis on cross-sectional volumetric brain alterations in both medicated and antipsychotic-naive patients was conducted. Three hundred seventeen studies published from September 1, 1998 to January 1, 2012 comprising over 9000 patients were selected for meta-analysis, including 33 studies in antipsychotic-naive patients. In addition to effect sizes, potential modifying factors such as duration of illness, sex composition, current antipsychotic dose, and intelligence quotient matching status of participants were extracted where available. In the sample of medicated schizophrenia patients (n = 8327), intracranial and total brain volume was significantly decreased by 2.0% (effect size d = -0.17) and 2.6% (d = -0.30), respectively. Largest effect sizes were observed for gray matter structures, with effect sizes ranging from -0.22 to -0.58. In the sample of antipsychotic-naive patients (n = 771), volume reductions in caudate nucleus (d = -0.38) and thalamus (d = -0.68) were more pronounced than in medicated patients. White matter volume was decreased to a similar extent in both groups, while gray matter loss was less extensive in antipsychotic-naive patients. Gray matter reduction was associated with longer duration of illness and higher dose of antipsychotic medication at time of scanning. Therefore, brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Heritability of cortical thickness changes over time in twin pairs discordant for schizophrenia

TL;DR: Excessive cortical thinning, particularly of the left superior temporal cortex, may represent a genetic risk marker for schizophrenia.
Journal ArticleDOI

Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.

TL;DR: Brain volume reductions associated with antipsychotic treatment are not restricted to poor outcome patients and occur even with the lowest effective dose of antipsychotics, at least in the short term.
Journal ArticleDOI

Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication

TL;DR: A novel finding is demonstrated that the caudate volume explains a significant amount of the variance in treatment response over the course of 6 weeks of risperidone pharmacotherapy even when controlling for baseline symptom severity and duration of illness.
Journal ArticleDOI

Common gray and white matter abnormalities in schizophrenia and bipolar disorder.

TL;DR: The study results suggest that GM volume deficits in the thalamus and insular lobe along with widespread disruptions of WM integrity might be the common neural mechanisms underlying the pathologies of SZ and BD.
Journal ArticleDOI

Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.

TL;DR: These findings provide first direct evidence of a disrupted prefrontocortical dopamine-stress regulation in schizophrenia and exploratory associations between ΔBPND or ΔAUCI and stress or anxiety measures observed in clinical high risk for psychosis were absent.
References
More filters
Book

Statistical Power Analysis for the Behavioral Sciences

TL;DR: The concepts of power analysis are discussed in this paper, where Chi-square Tests for Goodness of Fit and Contingency Tables, t-Test for Means, and Sign Test are used.
Journal ArticleDOI

Measuring inconsistency in meta-analyses

TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Journal ArticleDOI

Meta-Analysis of Regional Brain Volumes in Schizophrenia

TL;DR: In this article, the authors conducted a systematic search for structural magnetic resonance imaging (MRI) studies of patients with schizophrenia that reported volume measurements of selected cortical, subcortical, and ventricular regions in relation to comparison groups.
Journal ArticleDOI

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

TL;DR: By comparison with age-matched controls in employment, 17 institutionalised schizophrenic patients were shown by computerised axial tomography of the brain to have increased cerebral ventricular size.
Journal ArticleDOI

Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers

TL;DR: In this article, the authors quantitatively quantitate neuroanatomic parameters in healthy volunteers and compare the values with normative values from postmortem studies, using MRI images of 116 volunteers aged 19 months to 80 years.
Related Papers (5)

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

T.G.M. van Erp, +66 more
- 01 Apr 2016 - 

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke, +354 more
- 24 Jul 2014 -